TENA Reveals America’s Silent Incontinence Epidemic
PHILADELPHIA, July 18, 2024 /PRNewswire/ -- Incontinence is often associated with the elderly and infirm but new research by TENA,...
PHILADELPHIA, July 18, 2024 /PRNewswire/ -- Incontinence is often associated with the elderly and infirm but new research by TENA,...
The Column Group (TCG) led the round with participation from a select group of investorsPrimary sclerosing cholangitis (PSC) is a...
Meet the Families Behind Safe Haven Baby BoxesWOODBURN, IN / ACCESSWIRE / July 15, 2024 / Safe Haven Baby Boxes...
The first-of-its-kind collaboration combines personalized genetic insights with evidence-based treatments to provide accessible and effective obesity care for women MENLO...
Advanced Fertility Center of Texas (AFCT) is proud to announce that it has been recognized on Newsweek and Statista Inc.'s...
RESEARCH TRIANGLE PARK, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the General Directorate...
ROCKVILLE, MD / ACCESSWIRE / July 8, 2024 / Theralogix is proud to announce that TheraNatal® Complete has been featured...
MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than...
SNIPR BIOME receives funding from the Bill & Melinda Gates Foundation to accelerate the development of SNIPR Biome's microbial gene...
The efficacy and safety of tafenoquine in treating human babesiosis will be evaluated in a randomized, double-blind, placebo-controlled trial conducted...
WASHINGTON, June 26, 2024 /PRNewswire/ -- MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization...
The company's 8th AI model makes ultrasound easier for new ultrasound users to capture important fetal measurements VANCOUVER, BC, June...
MIAMI, FL, June 18, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
New analysis of the pivotal Phase 3 SOLOIST-WHF trial demonstrates INPEFA cost-effectiveness Findings consistent with another study recently published in...
In Study 502, lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key...
Houston, Texas--(Newsfile Corp. - June 17, 2024) - Cannabis Bioscience International Holdings (OTC PINK: CBIH) has been valued at $2...
NEW YORK, June 14, 2024 /PRNewswire/ -- The global smart weight, body composition, and BMI scales market size is estimated to grow by...
STOUGHTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed...
DENVER, June 12, 2024 /PRNewswire/ -- Momcozy, a leading provider of maternity products and nursing care, revolutionizes the market with...